Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
September 30, 2026 -6.00M
June 30, 2026 -9.544M
March 31, 2026 -9.00M
December 31, 2025 -97.00M
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 48.97M
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 0.00
Date Value
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.025M
March 31, 2020 0.00
December 31, 2019 0.015M
September 30, 2019 0.00
June 30, 2019 -0.10M
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.002M
June 30, 2017 -0.001M
March 31, 2017 -0.065M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Indaptus Therapeutics, Inc. 0.0882M
Cue Biopharma, Inc. 0.00
Yarrow Bioscience, Inc. -5.00M
Faeth Therapeutics, Inc. 0.175M
Pyxis Oncology, Inc. -37.29M